How one pharma “family business” places patients first
pharmaphorum
OCTOBER 26, 2022
The status isn’t awarded lightly and Chiesi is the largest pharmaceutical manufacturer to be named a B Corp. “We We promptly discussed this need with the FDA and the agency agreed to a proposed amendment of the protocol to accommodate, in a safe manner, the patient access to the EAP.”.
72 
Let's personalize your content